Sign InBreakout Stocks of Week 24 @ FRA
NASDAQ was down last week (week 23) by -4.70% ending at 25,709.43 points after falling -1,266.92 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Vaneck Morningstar Developed Markets Dividend Leaders Ucits Etf FRA:VDIV. This stock has had a buy signal since Jun 04, 2026 when the price was 51.70€ and is so far up 0.426% to 51.92€. Some other companies are on our watchlist to, among these are RWE Aktiengesellschaft FRA:RWE British American Tobacco p.l.c. FRA:BMT Deutsche Börse Aktiengesellschaft FRA:DB1 and Stellantis Nv FRA:8TI which all got a breakout pattern emerging.
| Date | Company | Price | Week 24 |
|---|---|---|---|
| Vaneck Morningstar Developed Markets Dividend Lead... | 51.92€ | 52.55€ | 1.21% |
| Rwe Aktiengesellschaft | 56.00€ | 57.46€ | 2.61% |
| British American Tobacco P.l.c. | 51.12€ | 53.68€ | 5.01% |
| Deutsche Börse Aktiengesellschaft | 245.90€ | 249.50€ | 1.46% |
| Stellantis Nv | 6.23€ | 5.91€ | -5.01% |
Vaneck Morningstar Developed Markets Dividend Leaders Ucits Etf
FRA:VDIVThe Vaneck Morningstar Developed Markets ETF price gained 0.426% on the last trading day (Friday, 5th Jun 2026), rising from 51.70€ to 51.92€. During the last trading day the ETF fluctuated 0.698% from a day low at 51.56€ to a day high of 51.92€. The price has fallen in 6 of the last 10 days and is down by -2.64% for this period. Volume fell on the last day by -14 thousand shares and in total, 95 thousand shares were bought and sold for approximately 4.93€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
The RWE Aktiengesellschaft stock price gained 0.358% on the last trading day (Friday, 5th Jun 2026), rising from 55.80€ to 56.00€. During the last trading day the stock fluctuated 1.25% from a day low at 55.86€ to a day high of 56.56€. The price has been going up and down for this period, and there has been a -1.13% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 84 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately 63.61€ million.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for RWE Aktiengesellschaft stock to perform well in the short-term period.
About RWE Aktiengesellschaft:
RWE Aktiengesellschaft generates and supplies electricity from renewable and conventional sources primarily in Europe and the United States. It operates through five segments: Offshore Wind; Onshore Wind/Solar; Hydro/Biomass/Gas; Supply & Trading; and Coal/Nuclear. The company generates wind, solar, hydro, nuclear, gas, and biomass electricity. It also trades in energy commodities; and operates gas storage facilities, as well as battery storage activities. The company serves commercial, industrial, and corporate customers. RWE Aktiengesellschaft was founded in 1898 and is headquartered in Essen, Germany.
The British American Tobacco p.l.c. stock price gained 2.32% on the last trading day (Friday, 5th Jun 2026), rising from 49.96€ to 51.12€. During the last trading day the stock fluctuated 3.72% from a day low at 49.50€ to a day high of 51.34€. The price has fallen in 9 of the last 10 days and is down by -9.62% for this period. Volume fell on the last day by -2 thousand shares and in total, 44 thousand shares were bought and sold for approximately 2.26€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
British American Tobacco p.l.c. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About British American Tobacco p.l.c.:
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour, tobacco heating, and modern oral nicotine products; combustible products; and traditional oral products, such as snus and moist snuff. The company offers its products under the Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Camel, Newport, Natural American Spirit, being Vapour, THP, and Modern Oral brands. It distributes its products to retail outlets. British American Tobacco p.l.c. was incorporated in 1902 and is headquartered in London, the United Kingdom.
The Deutsche Börse Aktiengesellschaft stock price gained 0.245% on the last trading day (Friday, 5th Jun 2026), rising from 245.30€ to 245.90€. During the last trading day the stock fluctuated 2.08% from a day low at 245.40€ to a day high of 250.50€. The price has fallen in 6 of the last 10 days and is down by -3.95% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 42 thousand more shares were traded than the day before. In total, 292 thousand shares were bought and sold for approximately 71.89€ million.
Deutsche Börse Aktiengesellschaft holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Deutsche Börse Aktiengesellschaft:
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine, or Ara-C, in patients with MDS; and a Phase 2a combination trial of ALRN-6924 and palbociclib in patients with tumors harboring MDM2 amplifications co-amplifications, as well as for patients with p53-mutated small cell lung cancer that has completed Phase 1b clinical trial. It has a license agreement with Dana-Farber Cancer Institute and Harvard College; and Umicore Precious Metals Chemistry USA, LLC. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts.
The Stellantis Nv stock price fell by -3.07% on the last day (Friday, 5th Jun 2026) from 6.42€ to 6.23€. During the last trading day the stock fluctuated 3.94% from a day low at 6.23€ to a day high of 6.47€. The price has fallen in 7 of the last 10 days and is down by -4.23% for this period. Volume has increased on the last day by 112 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 331 thousand shares were bought and sold for approximately 2.06€ million.
The Stellantis Nv stock holds several negative signals and despite the positive trend, we believe Stellantis Nv will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
NESR
$25.06
|
0.439% | Jun 22 |
IDYA
$28.98
|
25.19% | Jun 12 |
PHM
$118.49
|
14.53% | Jun 10 |
DHI
$146.71
|
13.50% | Jun 10 |
EAT
$140.46
|
20.94% | Jun 05 |
